Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

Congress nearly passed legislation to restrict pharmacy benefit manager business practices at the end of 2024.

For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.

Lawmakers determined to enact new restrictions on pharmacy benefit managers are trying to include legislation, which nearly passed in December, in a budget package that must pass by next month.

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...